How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

What are the latest DBD codes? These freebie-granting DBD redeemables can reward you with anything from a few bonus Bloodpoints to help prestige the latest character to new and exclusive in-game ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

As of September 2026, I rate the DraftKings offer highly for new bettors because it combines a low $5 qualifying wager with a bonus that’s spread over three weeks. Between the lines: You’ll get two ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Somer G. Anderson is CPA, doctor of accounting, and an accounting ...

Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...